Monday, December 23
Shadow

FDA Approves Remdesivir to Treat Hospitalized Covid-19 Patients Despite Mixed Trial Results

by admin

FDA Approves Remdesivir to Treat Hospitalized Covid-19 Patients Despite Mixed Trial Results

ftjtzicgwsgzngkegqnm

The Food and Drug Administration has approved remdesivir to treat hospitalized covid-19 patients. The antiviral drug, which is manufactured and sold by the pharmaceutical company Gilead under the brand name Veklury, is the first to be approved for treating the virus in the U.S.

Read more…

Go to Source

Related posts:

  1. Coronavirus US live: FDA approves experimental drug remdesivir for emergency use
  2. How Remdesivir, New Hope for Covid-19 Patients, Was Resurrected
  3. Remdesivir drug to be available for selected NHS Covid-19 patients
  4. Dyson Built a New Ventilator to Treat Covid-19 Patients, but Was Told the UK No Longer Needs It
  5. FDA approves first over-the-counter COVID-19 test that delivers near-instant results | New York Post

Terms and Conditions - Privacy Policy